Literature DB >> 11252900

Human cancer cell lines: fact and fantasy.

J R Masters1.   

Abstract

Cancer cell lines are used in many biomedical research laboratories. Why, then, are they often described as unrepresentative of the cells from which they were derived? Here, I argue that they have been unjustly accused. Under the right conditions, and with appropriate controls, properly authenticated cancer cell lines retain the properties of the cancers of origin.

Entities:  

Mesh:

Year:  2000        PMID: 11252900     DOI: 10.1038/35043102

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  89 in total

1.  Iron transport in cancer cell culture suspensions measured by cell magnetophoresis.

Authors:  Xiaoxia Jin; Jeffrey J Chalmers; Maciej Zborowski
Journal:  Anal Chem       Date:  2012-04-26       Impact factor: 6.986

2.  False cell lines: The problem and a solution.

Authors:  John R Masters
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

3.  Identification and verification of rodent cell lines by polymerase chain reaction.

Authors:  Klaus G Steube; Anne-Leena Koelz; Hans G Drexler
Journal:  Cytotechnology       Date:  2007-10-31       Impact factor: 2.058

Review 4.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.

Authors:  Logan C DeBord; Ravi R Pathak; Mariana Villaneuva; Hsuan-Chen Liu; Daniel A Harrington; Wendong Yu; Michael T Lewis; Andrew G Sikora
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers.

Authors:  Garrett M Dancik; Yuanbin Ru; Charles R Owens; Dan Theodorescu
Journal:  Cancer Res       Date:  2011-10-19       Impact factor: 12.701

6.  Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice.

Authors:  Sharif U Ahmed; Murtuza Zair; Kui Chen; Matthew Iu; Feng He; Oyedele Adeyi; Sean P Cleary; Anand Ghanekar
Journal:  J Vis Exp       Date:  2013-09-25       Impact factor: 1.355

7.  Assay-based response evaluation in head and neck oncology: requirements for better decision making.

Authors:  Andreas Dietz; Andreas Boehm; Iris-Susanne Horn; Pierre Kruber; Ingo Bechmann; Wojciech Golusinski; Dietger Niederwieser; Ralph Dollner; Torsten W Remmerbach; Christian Wittekind; Stephan Dietzsch; Guido Hildebrandt; Gunnar Wichmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-06       Impact factor: 2.503

8.  Patient derived cell culture and isolation of CD133⁺ putative cancer stem cells from melanoma.

Authors:  Yvonne Welte; Cathrin Davies; Reinhold Schäfer; Christian R A Regenbrecht
Journal:  J Vis Exp       Date:  2013-03-13       Impact factor: 1.355

9.  Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line.

Authors:  Hector Alvarez; Jan-Bart M Koorstra; Seung-Mo Hong; Jurjen J Boonstra; Winand N M Dinjens; Arlene A Foratiere; Tsung-Teh Wu; Elizabeth Montgomery; James R Eshleman; Anirban Maitra
Journal:  Cancer Biol Ther       Date:  2008-11-04       Impact factor: 4.742

10.  Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions.

Authors:  Cuiping Pan; Chanchal Kumar; Sebastian Bohl; Ursula Klingmueller; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2008-10-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.